These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7025751)

  • 41. [The bioavailability and clinical efficay of drylin, a new drug combination of TMP/SMZ].
    Rilling GJ
    Fortschr Med; 1977 Sep; 95(25):2167-70. PubMed ID: 410716
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on cerebrospinal fluid diffusion of trimethoprim in children].
    Fries N; Keuth U; Braun JS
    Fortschr Med; 1975 Sep; 93(25):1178-83. PubMed ID: 1213643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.
    Scheld WM; Brodeur JP; Sande MA; Alliegro GM
    Antimicrob Agents Chemother; 1982 Oct; 22(4):652-6. PubMed ID: 6217785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days.
    Johnson JR; Lyons MF; Pearce W; Gorman P; Roberts PL; White N; Brust P; Olsen R; Gnann JW; Stamm WE
    J Infect Dis; 1991 Feb; 163(2):325-30. PubMed ID: 1988516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
    Pelton SI; Shurin PA; Klein JO; Finland M
    Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.
    Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ
    Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.
    Bodey GP; Grose WE; Keating MJ
    Rev Infect Dis; 1982; 4(2):579-85. PubMed ID: 6981174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trimethoprim in pediatric urinary tract infection.
    Rajkumar S; Saxena Y; Rajagopal V; Sierra MF
    Child Nephrol Urol; 1988-1989; 9(1-2):77-81. PubMed ID: 3251626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Gratz JC; Foresman P; Rodeheaver G
    Antimicrob Agents Chemother; 1983 Nov; 24(5):682-8. PubMed ID: 6362552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients.
    Tolkoff-Rubin NE; Cosimi AB; Russell PS; Rubin RH
    Rev Infect Dis; 1982; 4(2):614-8. PubMed ID: 7051249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of PCP prophylaxis on bacteriuria incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients.
    van Dooyeweert DA; Schneider MM; Borleffs JC; Hoepelman AI
    Neth J Med; 1996 Dec; 49(6):225-7. PubMed ID: 8990860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trimethoprim-sulfamethoxazole for bacterial meningitis.
    Levitz RE; Quintiliani R
    Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.
    Markowitz N; Saravolatz LD
    Rev Infect Dis; 1987; 9 Suppl 2():S218-29. PubMed ID: 3495027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antimicrobial therapy of respiratory tract infections using ampicillin, doxycycline and TMP/SMZ].
    Nassif A; Reinhold K
    Med Welt; 1978 Feb; 29(7):277-81. PubMed ID: 622040
    [No Abstract]   [Full Text] [Related]  

  • 60. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
    Scheld WM; Fink FN; Fletcher DD; Sande MA
    Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.